# EDGAR Filing Document

**Accession Number:** 0001841619
**File Stem:** 0001753926-26-000402
**Filing Date:** 2026-2
**Character Count:** 24329
**Document Hash:** 125c37111ff316f53a45b83941a75f92
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001753926-26-000402.hdr.sgml**: 20260227

**ACCESSION NUMBER**: 0001753926-26-000402

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260227

**DATE AS OF CHANGE**: 20260227

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tivic Health Systems, Inc.
- **CENTRAL INDEX KEY:** 0001787740
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 814016391
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-93529
- **FILM NUMBER:** 26699596

**BUSINESS ADDRESS:**
- **STREET 1:** 47685 LAKEVIEW BLVD
- **CITY:** FREMONT
- **STATE:** CA
- **ZIP:** 94538
- **BUSINESS PHONE:** (888)276-6888

**MAIL ADDRESS:**
- **STREET 1:** 47685 LAKEVIEW BLVD
- **CITY:** FREMONT
- **STATE:** CA
- **ZIP:** 94538
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** 3i, LP
- **CENTRAL INDEX KEY:** 0001841619

**ORGANIZATION NAME:**
- **EIN:** 843800874
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G

**BUSINESS ADDRESS:**
- **STREET 1:** 874 WALKER ROAD
- **STREET 2:** SUITE C
- **CITY:** DOVER
- **STATE:** DE
- **ZIP:** 19904
- **BUSINESS PHONE:** (646) 845-0040

**MAIL ADDRESS:**
- **STREET 1:** 140 BROADWAY
- **STREET 2:** 38TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10005

## Ex-1

**EXHIBIT 1**

**JOINT FILING AGREEMENT**

**PURSUANT TO RULE 13d-1(k)**

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. The undersigned hereby further agree that this Joint Filing Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original, but all of which counterparts shall together constitute one and the same instrument.

---

| | | |
|:---|:---|:---|
| Date: February 27, 2026 | **3i, LP** | **3i, LP** |
|  | By: 3i Management LLC, | By: 3i Management LLC, |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;its General Partner | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;its General Partner |
|  | By: | /s/ Maier Joshua Tarlow |
|  |  | Name: Maier Joshua Tarlow |
|  |  | Title: Manager |
|  | **Tumim Stone Capital LLC** | **Tumim Stone Capital LLC** |
|  | By: 3i Management LLC, | By: 3i Management LLC, |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;its Manager | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;its Manager |
|  | By: | /s/ Maier Joshua Tarlow |
|  |  | Name: Maier Joshua Tarlow |
|  |  | Title: Manager |
|  | **3i Management LLC** | **3i Management LLC** |
|  | By: | /s/ Maier Joshua Tarlow |
|  |  | Name: Maier Joshua Tarlow |
|  |  | Title: Manager |
|  | /s/ Maier Joshua Tarlow | /s/ Maier Joshua Tarlow |
|  | Maier Joshua Tarlow | Maier Joshua Tarlow |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**Issuer:** Tivic Health Systems, Inc.

**Title of Class of Securities:** Common Stock, par value $0.0001 per share

**CUSIP Number:** 888705308

**Date of Event Which Requires Filing of this Statement:** 02/21/2026

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [x] Rule 13d-1(c)

- [ ] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>3i, LP | Names of Reporting Persons<br>3i, LP |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [x] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [x] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>276187.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>276187.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>276187.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>276187.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>9.9% | Percent of Class Represented by Amount in Row (9)<br>9.9% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

**Comment for Type of Reporting Person:** As more fully described in Item 4 of this statement on Schedule 13G (this ''Schedule 13G''), such shares and percentage are based on 2,535,509 shares of common stock, par value $0.0001 per share, of the issuer (the ''Common Stock'') outstanding as of February 5, 2026, as disclosed in the issuer's Definitive Proxy Statement on Schedule 14A, filed with the U.S. Securities and Exchange Commission (the ''SEC'') on February 9, 2026 (the ''Proxy Statement''). Beneficial ownership consists of 47,055 shares of Common Stock directly held by the reporting person and 229,132 shares of Common Stock issuable in any combination upon any (i) exercises of certain common stock purchase warrants (the ''Warrants'') held directly by the reporting person, which exercises are subject to a 9.99% beneficial ownership limitation provision (a ''Blocker''), (ii) conversions of a senior secured convertible note in the principal aggregate amount of approximately $16.3 million (the ''Note'') held directly by the reporting person, which conversions are subject to a Blocker, (iii) conversions of shares of Series B Convertible Preferred Stock, par value $0.0001 per share, of the issuer (the ''Series B Preferred Stock'') directly held by the reporting person, which conversions are subject to a Blocker, and (iv) conversions of shares of Series C Convertible Preferred Stock, par value $0.0001 per share, of the issuer (the ''Series C Preferred Stock'') directly held by the reporting person, which conversions are subject to a Blocker.

---

| 1. | Names of Reporting Persons<br>Tumim Stone Capital LLC | Names of Reporting Persons<br>Tumim Stone Capital LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [x] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [x] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>229132.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>229132.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>229132.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>229132.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>9.9% | Percent of Class Represented by Amount in Row (9)<br>9.9% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

**Comment for Type of Reporting Person:** As more fully described in Item 4 of this Schedule 13G, such shares and percentage are based on 2,535,509 shares of Common Stock outstanding as of February 5, 2026, as disclosed in the Proxy Statement. Beneficial ownership consists of 229,132 shares of Common Stock issuable upon any exercises of pre-funded common stock purchase warrants (''Pre-Funded Warrants'') held directly by the reporting person, which exercises are in each case subject to a Blocker.

---

| 1. | Names of Reporting Persons<br>3i Management LLC | Names of Reporting Persons<br>3i Management LLC |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [x] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [x] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>276187.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>276187.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>276187.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>276187.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>9.9% | Percent of Class Represented by Amount in Row (9)<br>9.9% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

**Comment for Type of Reporting Person:** As more fully described in Item 4 of this Schedule 13G, such shares and percentage are based on 2,535,509 shares of Common Stock outstanding as of February 5, 2026, as disclosed in the Proxy Statement. Beneficial ownership consists of 47,055 shares of Common Stock indirectly held by the reporting person and 229,132 shares of Common Stock issuable in any combination upon any (i) exercises of the Warrants and Pre-Funded Warrants held indirectly by the reporting person, which exercises are in each case subject to a Blocker, and (ii) conversions of the Note, shares Series B Preferred Stock and shares of Series C Preferred Stock indirectly held by the reporting person, which conversions are in each case subject to a Blocker.

---

| 1. | Names of Reporting Persons<br>Maier Joshua Tarlow | Names of Reporting Persons<br>Maier Joshua Tarlow |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [x] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [x] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>X1 | Citizenship or Place of Organization<br>X1 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>276187.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>276187.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>276187.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>276187.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>9.9% | Percent of Class Represented by Amount in Row (9)<br>9.9% |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |

**Comment for Type of Reporting Person:** As more fully described in Item 4 of this Schedule 13G, such shares and percentage are based on 2,535,509 shares of Common Stock outstanding as of February 5, 2026, as disclosed in the Proxy Statement. Beneficial ownership consists of 47,055 shares of Common Stock indirectly held by the reporting person and 229,132 shares of Common Stock issuable in any combination upon any (i) exercises of the Warrants and Pre-Funded Warrants held indirectly by the reporting person, which exercises are in each case subject to a Blocker, and (ii) conversions of the Note, shares of Series B Preferred Stock and shares of Series C Preferred Stock indirectly held by the reporting person, which conversions are in each case subject to a Blocker.

---

**Item 1(a). Name of Issuer:**
Tivic Health Systems, Inc.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
47685 Lakeview Boulevard, Fremont, CA 94538

**Item 2(a). Name of Person Filing:**
(i) 3i, LP, a Delaware limited partnership ("3i");

(ii) Tumim Stone Capital LLC, a Delaware limited liability company ("Tumim");

(iii) 3i Management LLC, a Delaware limited liability company ("3i Management''); and

(iv) Maier Joshua Tarlow ("Mr. Tarlow").

The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons". Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.

The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 1 to this Schedule 13G, pursuant to which such Reporting Persons have agreed to file this Schedule 13G and all subsequent amendments jointly in accordance with the provisions of Rule 13d-1(k) of the Act.

The filing of this Schedule 13G should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the shares of Common Stock reported herein.

**Item 2(b). Address of Principal Business Office:**
The principal business address of each of the Reporting Persons is 2 Wooster Street, 2nd Floor, New York, NY 10013.

**Item 2(c). Citizenship:**
3i is a Delaware limited partnership. Tumim is a Delaware limited liability company. 3i Management is a Delaware limited liability company. Mr. Tarlow is a citizen of the United States.

**Item 2(d). Title of Class of Securities:**
Common Stock, par value $0.0001 per share

**Item 2(e). CUSIP Number:**
888705308

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover pages to this Schedule 13G and is incorporated herein by reference for each such Reporting Person.
The share amounts and ownership percentages disclosed on such cover pages as of the date of this Schedule 13G are based on 2,535,509 shares of Common Stock outstanding as of February 5, 2026, as disclosed in the Proxy Statement. The Reporting Persons are filing this Schedule 13G as a result of 3i's delivery of a notice to the issuer on February 20, 2026, effective 61 days thereafter, to increase the Blockers in the Warrants, the Pre-Funded Warrants, the Note, the Certificate of Designation of Preferences, Rights and Limitations of the Series B Non-Voting Convertible Preferred Stock (the "Series B Certificate of Designation") and the Certificate of Designation of Preferences, Rights and Limitations of Series C Non-Voting Convertible Preferred Stock (the "Series C Certificate of Designation")  from 4.99% to 9.99%.
As of the date of this Schedule 13G, 3i holds (i) 47,055 shares of Common Stock, (ii) Warrants exercisable for up to 6,515,464 shares of Common Stock, which exercises are subject to a Blocker, (iii) the Note in the principal aggregate amount of approximately $16.3 million, which conversions are subject to a Blocker, (iv) 2,155 shares of Series B Preferred Stock, which conversions are subject to a Blocker, and (v) 6,000 shares of Series C Preferred Stock, which conversions are subject to a Blocker. As of the date of this Schedule 13G, Tumim holds Pre-Funded Warrants exercisable for up to 437,012 shares of Common Stock.
Due to the interaction between the Blockers in each of the Warrants, the Note, the Series B Certificate of Designation and the Series C Certificate of Designation, 3i may exercise the Warrants for and/or convert the Note, the shares of Series B Preferred Stock and the shares of Series C Preferred stock into, in any combination, an aggregate of 229,132 shares of Common Stock as a result of the triggering of the applicable Blockers, each of which prohibits 3i from exercising the Warrants for, or converting the Note, the shares of Series B Preferred Stock and the shares of Series C Preferred Stock into, shares of Common Stock if, as a result of such exercise or conversion, 3i, together with its affiliates and any persons acting as a group together with 3i or any of such affiliates, would beneficially own more than 9.99% of the total number of shares of Common Stock then issued and outstanding immediately after giving effect to such exercise or conversion.
Tumim beneficially owns an aggregate of 229,132 shares of Common Stock as a result of 3i's ownership of 47,055 shares of Common Stock and the triggering of the 9.99% Blocker contained in the Pre-Funded Warrants, which prohibits Tumim from exercising the Pre-Funded Warrants for shares of Common Stock if, as a result of such exercise, the holder thereof, together with its affiliates and any persons acting as a group together with such holder or any of such affiliates, would beneficially own more than 9.99% of the total number of shares of Common Stock then issued and outstanding immediately after giving effect to such exercise.
Consequently, 3i beneficially owns 276,187 shares of Common Stock (the "3i Shares") and Tumim beneficially owns 229,132 shares of Common Stock (the "Tumim Shares", and collectively with the 3i Shares, the "Shares"). 3i is the beneficial owner of the 3i Shares and has the power to dispose of and the power to vote the 3i Shares beneficially owned by it, which power may be exercised by 3i Management, the manager and general partner of 3i. Tumim is the beneficial owner of the Tumim Shares and has the power to dispose of and the power to vote the Tumim Shares beneficially owned by it, which power may be exercised by 3i Management, the manager and general partner of Tumim. Mr. Tarlow, as the manager of 3i Management, has shared power to vote and/or dispose of the Shares beneficially owned by each of 3i, Tumim and 3i Management. Mr. Tarlow does not directly own the Shares. By reason of the provisions of Rule 13d-3 of the Act, Mr. Tarlow may be deemed to beneficially own the Shares beneficially owned by 3i, Tumim and 3i Management, and 3i Management may be deemed to beneficially own the Shares beneficially owned by 3i and Tumim.

**(b) Percent of class:**

(A) 3i: 9.99%
(B) Tumim: 9.99%
(C) 3i Management: 9.99%
(D) Mr. Tarlow: 9.99%

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

(A) 3i: 0.00
(B) Tumim: 0.00
(C) 3i Management: 0.00
(D) Mr. Tarlow: 0.00

**(ii) Shared power to vote or to direct the vote:**

(A) 3i: 276,187.00
(B) Tumim: 229,132.00
(C) 3i Management: 276,187.00
(D) Mr. Tarlow: 276,187.00

**(iii) Sole power to dispose or to direct the disposition of:**

(A) 3i: 0.00
(B) Tumim: 0.00
(C) 3i Management: 0.00
(D) Mr. Tarlow: 0.00

**(iv) Shared power to dispose or to direct the disposition of:**

(A) 3i: 276,187.00
(B) Tumim: 229,132.00
(C) 3i Management: 276,187.00
(D) Mr. Tarlow: 276,187.00

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Not Applicable

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

See Exhibit 1 filed herewith.

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**3i, LP**

**Date:** 02/27/2026

**By:** /s/ Maier Joshua Tarlow

**Name & Title:** Maier Joshua Tarlow, Manager of 3i Management LLC, General Partner of 3i, LP

**Tumim Stone Capital LLC**

**Date:** 02/27/2026

**By:** /s/ Maier Joshua Tarlow

**Name & Title:** Maier Joshua Tarlow, Manager of 3i Management LLC, Manager of Tumim Stone Capital LLC

**3i Management LLC**

**Date:** 02/27/2026

**By:** /s/ Maier Joshua Tarlow

**Name & Title:** Maier Joshua Tarlow, Manager

**Maier Joshua Tarlow**

**Date:** 02/27/2026

**By:** /s/ Maier Joshua Tarlow

**Name & Title:** Maier Joshua Tarlow